title: Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring.
authors.affiliation: Department of Urology and Renal Transplantation, Hôpital Rangueil, Toulouse, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Vaessen
authors.forename: Nassim
authors.initials: N
authors.lastname: Kamar
authors.forename: Marion
authors.initials: M
authors.lastname: Mehrenberger
authors.forename: Catherine
authors.initials: C
authors.lastname: Mazerolles
authors.forename: Catherine
authors.initials: C
authors.lastname: Mengelle
authors.forename: Pascal
authors.initials: P
authors.lastname: Rischmann
authors.forename: Lionel
authors.initials: L
authors.lastname: Rostaing
authors.forename: Bernard
authors.initials: B
authors.lastname: Malavaud
mesh_terms: D001707:Biopsy, Needle; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy; D004279:DNA, Viral / Q000032:analysis; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D016133:Polymerase Chain Reaction / Q000379:methods; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy; D018570:Risk Assessment; D012720:Severity of Illness Index; D014184:Transplantation, Homologous; D014526:Urethritis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*
chemical_list: D004279:DNA, Viral; D015774:Ganciclovir